Hemlibra 30mg Injection

Hemlibra 30mg Injection contains Emicizumab, a bispecific monoclonal antibody used to prevent bleeding in patients with hemophilia A, with or without inhibitors to factor VIII. It restores the blood clotting process and lowers the risk of bleeding episodes by bridging active factor IX and factor X.

Brand Name: Hemlibra

Composition: Emicizumab

Mechanism of Action:

A bispecific monoclonal antibody called Hemlibra binds to Factor IXa and Factor VIIIa at the same time, thereby bridging their relationship. The function of Factor VIII, which is lacking in hemophilia A patients, is mimicked by this mechanism. Hemlibra lowers the risk of bleeding episodes in hemophilia A patients by regulating the coagulation cascade and restoring the intrinsic tenase complex activity.

Uses:

Hemophilia A

Dosage and Administration:

Administration Route is Subcutaneous injection. usually in the thigh or abdomen. To lessen tissue reactivity or discomfort, rotate the areas.

Side Effects:

• Injection site reactions (redness, pain, swelling)
• Headache
• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Fatigue

Safety Advises:

Liver  

Periodic tests for liver function are recommended as the drug can cause toxicity, especially in patients with pre-existing conditions. Kindly speak with your healthcare provider.

Kidney  

Periodic tests for kidney function are recommended as the drug can cause toxicity, especially in patients with pre-existing conditions. Kindly speak with your healthcare provider.

Pregnancy  

Hemlibra is contraindicated in pregnancy due to the risk of fetal harm. Kindly speak with your healthcare provider.

Breast Feeding  

Breastfeeding should be avoided, as the drug can be excreted in breast milk. Kindly speak with your healthcare provider.

Storage:

Store Hemlibra Injection in the refrigerator at 2-8°C, protected from light, and avoid freezing.

How to use this Medication?

Once a week for four weeks, then every one, two, or four weeks as your doctor prescribes, emicizumab is injected subcutaneously. Pay close attention to the directions on your prescription and take the drug exactly as directed.

The injection of emicizumab is supplied in single-use vials. Before injecting the drug, let the vial come to room temperature for fifteen minutes out of direct sunlight. Never attempt to reheat the drug by submerging it in hot water, heating it in a microwave, or using any other technique. Used vials, needles, and syringes should be disposed away in a container that can withstand punctures. For information on how to get rid of the puncture-resistant container, speak with your pharmacist or doctor.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Roche Products India Pvt Ltd

Address: 1503, 15th Floor, ‘The Capital’, Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Country of origin: Switzerland